Sign In
Buy SEEL
$0.400
+0 (+0%)
At Close: Feb 14, 2025
These 4 Penny Stocks Are Down Today, Time to Buy the Dip?
11:47am, Friday, 21'st May 2021
Looking for penny stocks to buy at a steal? Check these 3 out for some watchlist inspiration The post These 4 Penny Stocks Are Down Today, Time to Buy the Dip?
Seelos Therapeutics to Participate in The Benchmark Company Healthcare Conference
08:00am, Friday, 21'st May 2021
NEW YORK, May 21, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorder
Seelos Therapeutics Announces Pricing of $60 Million Public Offering of Common Stock
08:19am, Thursday, 20'th May 2021
NEW YORK, May 20, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) di
Best Penny Stocks to Invest in 2021? Here's 3 To Check Out
05:18pm, Wednesday, 19'th May 2021
Top penny stocks in 2021? Check these 3 out for some watchlist inspiration The post Best Penny Stocks to Invest in 2021?
Seelos Therapeutics Announces Proposed Public Offering of Common Stock
04:01pm, Wednesday, 19'th May 2021
NEW YORK, May 19, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) dis
Do Options Traders Know Something About Seelos (SEEL) Stock We Don't?
09:46am, Wednesday, 19'th May 2021
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.
Seelos Therapeutics (SEEL) Stock: Over 17% Decrease Explanation
02:23pm, Tuesday, 18'th May 2021
The stock price of Seelos Therapeutics Inc (NASDAQ: SEEL) decreased by over 17% during intraday trading. This is why it happened.
Why Seelos Therapeutics Dived by 24% Today
06:52pm, Monday, 17'th May 2021
Good news from a clinical study was overshadowed by a recommendation downgrade from an analyst.
Seelos Therapeutics Inc (NASDAQ: SEEL) has announced data from Part 1, the open-label cohort, of its Proof-of-Concept study of SLS-002 for acute suicidal ideation and behavior in patients with Maj
Seelos Therapeutics Announces Positive Topline Data from the Open-Label Study of SLS-002 (Intranasal Racemic Ketamine), Demonstrating a Significant Treatment Effect and a Well Tolerated Safety Profile for Acute Suicidal Ideation and Behavior in Patients with Major Depressive Disorder
06:00am, Monday, 17'th May 2021
NEW YORK, May 17, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system (CNS) di
Seelos Therapeutics to Participate in the 2021 RBC Capital Markets Global Healthcare Conference
08:00am, Monday, 19'th Apr 2021
NEW YORK, April 19, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disord
Seelos Therapeutics to Participate in the B. Riley Securities' Neuroscience Conference
09:00am, Thursday, 15'th Apr 2021
NEW YORK, April 15, 2021 /PRNewswire/ -- Seelos Therapeutics, Inc. (Nasdaq: SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorde
Do Options Traders Know Something About Seelos (SEEL) Stock We Don't?
09:05am, Friday, 09'th Apr 2021
Investors need to pay close attention to Seelos (SEEL) stock based on the movements in the options market lately.
SEEL Stock Price Increased 56.25%: Why It Happened
05:24am, Saturday, 13'th Mar 2021
The stock price of Seelos Therapeutics, Inc. (Nasdaq: SEEL) increased by 56.25% yesterday. This is why it happened.
SEEL Stock: Why Biotech Play Seelos Therapeutics Is Soaring Today
02:14pm, Friday, 12'th Mar 2021
SEEL stock has received a massive vote of confidence from a BTIG analyst today who placed a $14 price target on this biotech stock. The post SEEL Stock: Why Biotech Play Seelos Therapeutics Is Soaring
